FRE47.08+0.56%
FRE · DAX
1y range: 35.45 → 47.15 · as of 2026-08-14
Next earnings
2026-11-04
in 79d
Recent material news
- Fresenius SE & Co. KGaA : UBS bevestigt koopadvies - MarketScreener Nederland — MarketScreener Nederland2026-08-12T10:29
- Fresenius SE & Co KGaA (FSNUY) (Q2 2026) Earnings Call Highlights: Raises Full-Year EPS ...2026-08-05T19:04
- Fresenius verhoogt winstverwachting voor 2026 - MarketScreener Nederland — MarketScreener Nederland2026-08-05T07:10
- Fresenius verhoogt prognose voor kernwinst per aandeel voor boekjaar 2026 - MarketScreener Nederland — MarketScreener Nederland2026-08-05T03:08
- Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market2026-08-03T20:09
- Turning Point Brands voor winsttest nu schattingen kelderen - Investing.com — Investing.com2026-08-03T18:46
- Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate2026-07-31T11:00
- Chemed (CHE) Tops Q2 Earnings and Revenue Estimates2026-07-28T22:00
Want this depth on every stock you watch?
ThickerPeek writes a daily AI digest on 165+ stocks, weekly theses, earnings briefings, and alerts — for €19/mo. Free tier available.
Not investment advice. ThickerPeek is a research tool. AI-written content is informational, not a buy/sell recommendation. Investment decisions are your own responsibility.